Novel Biotech-Based Field or Lab Assay for Detection of Fluoride
|
By LabMedica International staff writers Posted on 26 Dec 2019 |

Image: The test tube on the left shows a real positive result from water sampled in Costa Rica. The middle tube is a negative control. The tube on the right is a positive control (Photo courtesy of Dr. Julius B. Lucks, Northwestern University)
A simple, yet sophisticated biotech-based assay for the detection of fluoride levels was successfully tested in the laboratory and in the field.
Around one-third of the human population drinks water from groundwater resources. Of this, about 10%, approximately three hundred million people, obtain water from groundwater resources that are heavily contaminated with arsenic or fluoride. When consumed in high amounts over long periods of time, fluoride can cause skeletal fluorosis, a painful condition that hardens bones and joints.
Current laboratory methods to measure fluoride levels in groundwater are expensive and time consuming and may not be available in developing countries. Investigators at Northwestern University (Evanston, IL, USA) suggest replacing this methodology with a rapid, easy-to-use, inexpensive biotech-based assay.
This assay comprises a biosensor consisting of a cell-free system containing a DNA template that encodes a fluoride-responsive riboswitch, which regulates genes that produce a fluorescent or colorimetric output. A riboswitch is a regulatory segment of a messenger RNA molecule that binds a small molecule, resulting in a change in production of the proteins encoded by the mRNA. Thus, an mRNA that contains a riboswitch is directly involved in regulating its own activity, in response to the concentrations of its effector molecule. In the current assay system, the presence of fluoride causes the RNA to produce a protein enzyme that makes a yellow pigment that is readily visible to the naked eye.
Senior author Dr. Julius Lucks, associate professor of chemical and biological engineering at Northwestern University, said, "RNA folds into a little pocket and waits for a fluoride ion. The ion can fit perfectly into that pocket. If the ion shows up, then RNA expresses a gene that turns the water yellow. If the ion does not show up, then RNA changes shape and stops the process. It is literally a switch."
Reagents for individualized tests may be lyophilized for long-term storage. Following reconstitution with 20 microliters of liquid sample and incubation at room temperature for two hours, the test could detect fluoride at levels above two parts per million, the [U.S.] Environmental Protection Agency’s most stringent regulatory standard, in both laboratory and field conditions.
The prototype assay was successfully tested in Costa Rica, where the Irazu volcano causes heavy contamination of the groundwater with fluoride.
"In the United States, we hear about fluoride all the time because it is in toothpaste and the municipal water supply," said Dr. Lucks. "It makes calcium fluoride, which is very hard, so it strengthens our tooth enamel. But above a certain level, fluoride also hardens joints. This mostly is not an issue in the United States. But it can be a debilitating problem in other countries if not identified and addressed. Every test on these field samples worked. It is exciting that it works in the lab, but it is much more important to know that it works in the field. We want it to be an easy, practical solution for people who have the greatest need. Our goal is to empower individuals to monitor the presence of fluoride in their own water."
The fluoride detection test was described in the December 13, 2019, online edition of the journal ACS Synthetic Biology.
Related Links:
Northwestern University
Around one-third of the human population drinks water from groundwater resources. Of this, about 10%, approximately three hundred million people, obtain water from groundwater resources that are heavily contaminated with arsenic or fluoride. When consumed in high amounts over long periods of time, fluoride can cause skeletal fluorosis, a painful condition that hardens bones and joints.
Current laboratory methods to measure fluoride levels in groundwater are expensive and time consuming and may not be available in developing countries. Investigators at Northwestern University (Evanston, IL, USA) suggest replacing this methodology with a rapid, easy-to-use, inexpensive biotech-based assay.
This assay comprises a biosensor consisting of a cell-free system containing a DNA template that encodes a fluoride-responsive riboswitch, which regulates genes that produce a fluorescent or colorimetric output. A riboswitch is a regulatory segment of a messenger RNA molecule that binds a small molecule, resulting in a change in production of the proteins encoded by the mRNA. Thus, an mRNA that contains a riboswitch is directly involved in regulating its own activity, in response to the concentrations of its effector molecule. In the current assay system, the presence of fluoride causes the RNA to produce a protein enzyme that makes a yellow pigment that is readily visible to the naked eye.
Senior author Dr. Julius Lucks, associate professor of chemical and biological engineering at Northwestern University, said, "RNA folds into a little pocket and waits for a fluoride ion. The ion can fit perfectly into that pocket. If the ion shows up, then RNA expresses a gene that turns the water yellow. If the ion does not show up, then RNA changes shape and stops the process. It is literally a switch."
Reagents for individualized tests may be lyophilized for long-term storage. Following reconstitution with 20 microliters of liquid sample and incubation at room temperature for two hours, the test could detect fluoride at levels above two parts per million, the [U.S.] Environmental Protection Agency’s most stringent regulatory standard, in both laboratory and field conditions.
The prototype assay was successfully tested in Costa Rica, where the Irazu volcano causes heavy contamination of the groundwater with fluoride.
"In the United States, we hear about fluoride all the time because it is in toothpaste and the municipal water supply," said Dr. Lucks. "It makes calcium fluoride, which is very hard, so it strengthens our tooth enamel. But above a certain level, fluoride also hardens joints. This mostly is not an issue in the United States. But it can be a debilitating problem in other countries if not identified and addressed. Every test on these field samples worked. It is exciting that it works in the lab, but it is much more important to know that it works in the field. We want it to be an easy, practical solution for people who have the greatest need. Our goal is to empower individuals to monitor the presence of fluoride in their own water."
The fluoride detection test was described in the December 13, 2019, online edition of the journal ACS Synthetic Biology.
Related Links:
Northwestern University
Latest Technology News
- Online Tool Supports Family Screening for Inherited Cancer Risk
- Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
- New Electronic Pipette Enhances Workflows with Touchscreen Control
- AI Model Outperforms Clinicians in Rare Disease Detection
- AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
- Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms
- AI-Powered Biomarker Predicts Liver Cancer Risk
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Channels
Clinical Chemistry
view channel
Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, with more than 60% of cases still diagnosed at a late stage. Uptake of existing screening tools remains suboptimal,... Read more
Automated NfL Assay Supports Monitoring of Neurological Disorders
Neuroaxonal injury occurs across a wide range of neurological disorders and remains difficult to monitor noninvasively over time. Blood-based measurement of neurofilament light chain (NfL) provides a biologically... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read more
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more








